157 related articles for article (PubMed ID: 36097589)
1.
Zhang LY; Sun XW; Ding YJ; Yan YR; Wang Y; Li CX; Li SQ; Zhang L; Song HJ; Li HP; Li QY
Int J Chron Obstruct Pulmon Dis; 2022; 17():2117-2125. PubMed ID: 36097589
[TBL] [Abstract][Full Text] [Related]
2. Methylation of SERPINA1 gene promoter may predict chronic obstructive pulmonary disease in patients affected by acute coronary syndrome.
Rotondo JC; Aquila G; Oton-Gonzalez L; Selvatici R; Rizzo P; De Mattei M; Pavasini R; Tognon M; Campo GC; Martini F
Clin Epigenetics; 2021 Apr; 13(1):79. PubMed ID: 33858475
[TBL] [Abstract][Full Text] [Related]
3. Analysis of aberrant methylation on promoter sequences of tumor suppressor genes and total DNA in sputum samples: a promising tool for early detection of COPD and lung cancer in smokers.
Guzmán L; Depix MS; Salinas AM; Roldán R; Aguayo F; Silva A; Vinet R
Diagn Pathol; 2012 Jul; 7():87. PubMed ID: 22818553
[TBL] [Abstract][Full Text] [Related]
4. SERPINA1 Hepatocyte-Specific Promoter Polymorphism Associate with Chronic Obstructive Pulmonary Disease in a Study of Kashmiri Ancestry Individuals.
Bashir A; Hazari YM; Bashir S; Hilal N; Banday M; Iqbal MK; Jan TR; Farooq SS; Shah NN; Fazili KM
Lung; 2018 Aug; 196(4):447-454. PubMed ID: 29804144
[TBL] [Abstract][Full Text] [Related]
5. SERPINA1 methylation and lung function in tobacco-smoke exposed European children and adults: a meta-analysis of ALEC population-based cohorts.
Beckmeyer-Borowko A; Imboden M; Rezwan FI; Wielscher M; Amaral AFS; Jeong A; Schaffner E; Auvinen J; Sebert S; Karhunen V; Bettschart R; Turk A; Pons M; Stolz D; Kronenberg F; Arathimos R; Sharp GC; Relton C; Henderson AJ; Jarvelin MR; Jarvis D; Holloway JW; Probst-Hensch NM
Respir Res; 2018 Aug; 19(1):156. PubMed ID: 30134983
[TBL] [Abstract][Full Text] [Related]
6. SERPINA1 11478G→A variant, serum α1-antitrypsin, exacerbation frequency and FEV1 decline in COPD.
Quint JK; Donaldson GC; Kumari M; Talmud PJ; Hurst JR
Thorax; 2011 May; 66(5):418-24. PubMed ID: 21335450
[TBL] [Abstract][Full Text] [Related]
7. Profile of epigenetic mechanisms in lung tumors of patients with underlying chronic respiratory conditions.
Mateu-Jimenez M; Curull V; Rodríguez-Fuster A; Aguiló R; Sánchez-Font A; Pijuan L; Gea J; Barreiro E
Clin Epigenetics; 2018; 10():7. PubMed ID: 29371906
[TBL] [Abstract][Full Text] [Related]
8. SERPINA1 and ELA2 polymorphisms are not associated with COPD or lung cancer.
Enewold L; Mechanic LE; Bowman ED; Platz EA; Alberg AJ
Anticancer Res; 2012 Sep; 32(9):3923-8. PubMed ID: 22993338
[TBL] [Abstract][Full Text] [Related]
9. Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function.
Qiu W; Baccarelli A; Carey VJ; Boutaoui N; Bacherman H; Klanderman B; Rennard S; Agusti A; Anderson W; Lomas DA; DeMeo DL
Am J Respir Crit Care Med; 2012 Feb; 185(4):373-81. PubMed ID: 22161163
[TBL] [Abstract][Full Text] [Related]
10. IL-11 and CCL-1: Novel Protein Diagnostic Biomarkers of Lung Adenocarcinoma in Bronchoalveolar Lavage Fluid (BALF).
Pastor MD; Nogal A; Molina-Pinelo S; Quintanal-Villalonga Á; Meléndez R; Ferrer I; Romero-Romero B; De Miguel MJ; López-Campos JL; Corral J; García-Carboner R; Carnero A; Paz-Ares L
J Thorac Oncol; 2016 Dec; 11(12):2183-2192. PubMed ID: 27524264
[TBL] [Abstract][Full Text] [Related]
11. Alternative poly-adenylation modulates α1-antitrypsin expression in chronic obstructive pulmonary disease.
Lackey L; Coria A; Ghosh AJ; Grayeski P; Hatfield A; Shankar V; Platig J; Xu Z; Ramos SBV; Silverman EK; Ortega VE; Cho MH; Hersh CP; Hobbs BD; Castaldi P; Laederach A
PLoS Genet; 2021 Nov; 17(11):e1009912. PubMed ID: 34784346
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of a series of inflammatory markers in COPD for lung cancer diagnosis: a case-control study.
Mouronte-Roibás C; Leiro-Fernández V; Ruano-Raviña A; Ramos-Hernández C; Casado-Rey P; Botana-Rial M; García-Rodríguez E; Fernández-Villar A
Respir Res; 2019 Aug; 20(1):198. PubMed ID: 31455338
[TBL] [Abstract][Full Text] [Related]
13. Circulating miR-206 and miR-1246 as Markers in the Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease.
Córdoba-Lanús E; Domínguez de-Barros A; Oliva A; Mayato D; Gonzalvo F; Remírez-Sanz A; Zulueta JJ; Celli B; Casanova C
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569812
[TBL] [Abstract][Full Text] [Related]
14. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
[TBL] [Abstract][Full Text] [Related]
15. Systemic and Tumor Th1 and Th2 Inflammatory Profile and Macrophages in Lung Cancer: Influence of Underlying Chronic Respiratory Disease.
Mateu-Jimenez M; Curull V; Pijuan L; Sánchez-Font A; Rivera-Ramos H; Rodríguez-Fuster A; Aguiló R; Gea J; Barreiro E
J Thorac Oncol; 2017 Feb; 12(2):235-248. PubMed ID: 27793775
[TBL] [Abstract][Full Text] [Related]
16. Expression and methylation of mitochondrial transcription factor a in chronic obstructive pulmonary disease patients with lung cancer.
Peng H; Yang M; Chen ZY; Chen P; Guan CX; Xiang XD; Cai S; Chen Y; Fang X
PLoS One; 2013; 8(12):e82739. PubMed ID: 24367550
[TBL] [Abstract][Full Text] [Related]
17. PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort.
Sawa K; Koh Y; Kawaguchi T; Kambayashi S; Asai K; Mitsuoka S; Kimura T; Yoshimura N; Yoshimoto N; Kubo A; Saka H; Matsumura A; Wanibuchi H; Yamamoto N; Nishiyama N; Hirata K
Lung Cancer; 2017 Oct; 112():96-101. PubMed ID: 29191607
[TBL] [Abstract][Full Text] [Related]
18. Development of novel microarray methodology for the study of mutations in the SERPINA1 and ADRB2 genes--their association with Obstructive Pulmonary Disease and Disseminated Bronchiectasis in Greek patients.
Papatheodorou A; Makrythanasis P; Kaliakatsos M; Dimakou A; Orfanidou D; Roussos C; Kanavakis E; Tzetis M
Clin Biochem; 2010 Jan; 43(1-2):43-50. PubMed ID: 19747908
[TBL] [Abstract][Full Text] [Related]
19. High expression of SPP1 in patients with chronic obstructive pulmonary disease (COPD) is correlated with increased risk of lung cancer.
Miao TW; Xiao W; Du LY; Mao B; Huang W; Chen XM; Li C; Wang Y; Fu JJ
FEBS Open Bio; 2021 Apr; 11(4):1237-1249. PubMed ID: 33626243
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of chronic obstructive pulmonary disease-related non-small cell lung cancer through aberrant methylation and alterations of EGFR signaling.
Suzuki M; Wada H; Yoshino M; Tian L; Shigematsu H; Suzuki H; Alaa M; Tamura H; Fujiwara T; Nagato K; Motohashi S; Moriya Y; Hoshino H; Yoshida S; Shibuya K; Hiroshima K; Nakatani Y; Yoshino I
Ann Surg Oncol; 2010 Mar; 17(3):878-88. PubMed ID: 19841986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
